Volkow, N. D., Compton, W. M. & Weiss, S. R. Adverse health effects of marijuana use. N. Engl. J. Med. 371, 879 (2014).
Moore, T. H. et al. Cannabis use and risk of psychotic or affective mental health outcomes: a systematic review. Lancet 370, 319–328 (2007).
Hall, W. & Degenhardt, L. Adverse health effects of non-medical cannabis use. Lancet 374, 1383–1391 (2009).
Verweij, K. J. H. et al. Genetic and environmental influences on cannabis use initiation and problematic use: a meta-analysis of twin studies. Addiction 105, 417–430 (2010).
Agrawal, A., Neale, M. C., Jacobson, K. C., Prescott, C. A. & Kendler, K. S. Illicit drug use and abuse/dependence: modeling of two-stage variables using the CCC approach. Addict. Behav. 30, 1043–1048 (2005).
Agrawal, A. & Lynskey, M. T. The genetic epidemiology of cannabis use, abuse and dependence. Addiction 101, 801–812 (2006).
Verweij, K. J. H. et al. The genetic aetiology of cannabis use initiation: a meta-analysis of genome-wide association studies and a SNP-based heritability estimation. Addict. Biol. 18, 846–850 (2013).
Agrawal, A. et al. A genome-wide association study of DSM-IV cannabis dependence. Addict. Biol. 16, 514–518 (2011).
Minica, C. C. et al. Heritability, SNP- and gene-based analyses of cannabis use initiation and age at onset. Behav. Genet. 45, 503–513 (2015).
Stringer, S. et al. Genome-wide association study of lifetime cannabis use based on a large meta-analytic sample of 32 330 subjects from the International Cannabis Consortium. Transl. Psychiatry 6, e769 (2016).
Demontis, D. et al. Genome-wide association study implicates CHRNA2 in cannabis use disorder. Preprint at bioRxiv https://doi.org/10.1101/237321 (2018).
Gelernter, J. et al. Haplotype spanning TTC12 and ANKK1, flanked by the DRD2 and NCAM1 loci, is strongly associated to nicotine dependence in two distinct American populations. Hum. Mol. Genet. 15, 3498–3507 (2006).
Yang, B. Z. et al. Association of haplotypic variants in DRD2, ANKK1, TTC12 and NCAM1 to alcohol dependence in independent case control and family samples. Hum. Mol. Genet. 16, 2844–2853 (2007).
Clarke, T.-K. et al. Genome-wide association study of alcohol consumption and genetic overlap with other health-related traits in UK Biobank (N = 112 117). Mol. Psychiatry 22, 1376–1384 (2017).
Boutwell, B. et al. Replication and characterization of CADM2 and MSRA genes on human behavior. Heliyon 3, e00349 (2017).
Day, F. R. et al. Physical and neurobehavioral determinants of reproductive onset and success. Nat. Genet. 48, 617–623 (2016).
Andréasson, S., Allebeck, P., Engström, A. & Rydberg, U. Cannabis and schizophrenia. A longitudinal study of Swedish conscripts. Lancet 2, 1483–1486 (1987).
Smit, F., Bolier, L. & Cuijpers, P. Cannabis use and the risk of later schizophrenia: a review. Addiction 99, 425–430 (2004).
Volkow, N. D. et al. Effects of cannabis use on human behavior, including cognition, motivation, and psychosis: a review. JAMA Psychiatry 73, 292–297 (2016).
Verweij, K. J. et al. Short communication: Genetic association between schizophrenia and cannabis use. Drug Alcohol Depend. 171, 117–121 (2017).
Power, R. A. et al. Genetic predisposition to schizophrenia associated with increased use of cannabis. Mol. Psychiatry 19, 1201–1204 (2014).
Burgess, S., Scott, R. A., Timpson, N. J., Davey Smith, G. & Thompson, S. G. Using published data in Mendelian randomization: a blueprint for efficient identification of causal risk factors. Eur. J. Epidemiol. 30, 543–552 (2015).
Vaucher, J. et al. Cannabis use and risk of schizophrenia: a Mendelian randomization study. Mol. Psychiatry 23, 1287–1292 (2018).
Gage, S. H. et al. Assessing causality in associations between cannabis use and schizophrenia risk: a two-sample Mendelian randomization study. Psychol. Med. 47, 971–980 (2017).
de Leeuw, C. A., Mooij, J. M., Heskes, T. & Posthuma, D. MAGMA: generalized gene-set analysis of GWAS data. PLOS Comput. Biol. 11, e1004219 (2015).
Barbeira, A.N. et al. Exploring the phenotypic consequences of tissue specific gene expression variation inferred from GWAS summary statistics. Preprint at bioRxiv https://doi.org/10.1101/045260 (2017).
Bowden, J., Davey Smith, G. & Burgess, S. Mendelian randomization with invalid instruments: effect estimation and bias detection through Egger regression. Int. J. Epidemiol. 44, 512–525 (2015).
Burgess, S. & Thompson, S. G. Interpreting findings from Mendelian randomization using the MR-Egger method. Eur. J. Epidemiol. 32, 377–389 (2017).
Ibrahim-Verbaas, C. A. et al. GWAS for executive function and processing speed suggests involvement of the CADM2 gene. Mol. Psychiatry 21, 189–197 (2016).
Walther, B., Morgenstern, M. & Hanewinkel, R. Co-occurrence of addictive behaviours: personality factors related to substance use, gambling and computer gaming. Eur. Addict. Res. 18, 167–174 (2012).
Martin, C. A. et al. Sensation seeking, puberty, and nicotine, alcohol, and marijuana use in adolescence. J. Am. Acad. Child Adolesc. Psychiatry 41, 1495–1502 (2002).
Nielsen, J., Kulahin, N. & Walmod, P. S. Extracellular protein interactions mediated by the neural cell adhesion molecule, NCAM: heterophilic interactions between NCAM and cell adhesion molecules, extracellular matrix proteins, and viruses. Adv. Exp. Med. Biol. 663, 23–53 (2010).
Rubinek, T. et al. The cell adhesion molecules N-cadherin and neural cell adhesion molecule regulate human growth hormone: a novel mechanism for regulating pituitary hormone secretion. J. Clin. Endocrinol. Metab. 88, 3724–3730 (2003).
Ducci, F. et al. TTC12-ANKK1-DRD2 and CHRNA5-CHRNA3-CHRNB4 influence different pathways leading to smoking behavior from adolescence to mid-adulthood. Biol. Psychiatry 69, 650–660 (2011).
Bidwell, L. C. et al. NCAM1-TTC12-ANKK1-DRD2 variants and smoking motives as intermediate phenotypes for nicotine dependence. Psychopharmacology (Berl.) 232, 1177–1186 (2015).
Atz, M. E., Rollins, B. & Vawter, M. P. NCAM1 association study of bipolar disorder and schizophrenia: polymorphisms and alternatively spliced isoforms lead to similarities and differences. Psychiatr. Genet. 17, 55–67 (2007).
Petrovska, J. et al. The NCAM1 gene set is linked to depressive symptoms and their brain structural correlates in healthy individuals. J. Psychiatr. Res. 91, 116–123 (2017).
Weiss, L. A. et al. Association between microdeletion and microduplication at 16p11.2 and autism. N. Engl. J. Med. 358, 667–675 (2008).
McCarthy, S. E. et al. Microduplications of 16p11.2 are associated with schizophrenia. Nat. Genet. 41, 1223–1227 (2009).
González, J. R. et al. A common 16p11.2 inversion underlies the joint susceptibility to asthma and obesity. Am. J. Hum. Genet. 94, 361–372 (2014).
Zuo, L. et al. Genome-wide significant association signals in IPO11-HTR1A region specific for alcohol and nicotine codependence. Alcohol. Clin. Exp. Res. 37, 730–739 (2013).
Speliotes, E. K. et al. Association analyses of 249,796 individuals reveal 18 new loci associated with body mass index. Nat. Genet. 42, 937–948 (2010).
Donaldson, Z. R. et al. The functional serotonin 1a receptor promoter polymorphism, rs6295, is associated with psychiatric illness and differences in transcription. Transl. Psychiatry 6, e746 (2016).
Gatt, J. M., Burton, K. L., Williams, L. M. & Schofield, P. R. Specific and common genes implicated across major mental disorders: a review of meta-analysis studies. J. Psychiatr. Res. 60, 1–13 (2015).
Takekita, Y. et al. HTR1A polymorphisms and clinical efficacy of antipsychotic drug treatment in schizophrenia: a meta-analysis. Int. J. Neuropsychopharmacol. 19, pyv125 (2016).
Sherva, R. et al. Genome-wide association study of cannabis dependence severity, novel risk variants, and shared genetic risks. JAMA Psychiatry 73, 472–480 (2016).
Patrick, M. E., Wightman, P., Schoeni, R. F. & Schulenberg, J. E. Socioeconomic status and substance use among young adults: a comparison across constructs and drugs. J. Stud. Alcohol Drugs 73, 772–782 (2012).
Müller-Vahl, K. R. & Emrich, H. M. Cannabis and schizophrenia: towards a cannabinoid hypothesis of schizophrenia. Expert Rev. Neurother. 8, 1037–1048 (2008).
Abecasis, G. R. et al. An integrated map of genetic variation from 1,092 human genomes. Nature 491, 56–65 (2012).
McCarthy, S. & Das, S. A reference panel of 64,976 haplotypes for genotype imputation. Nat. Genet. 48, 1279–1283 (2016).
Chang, C. C. et al. Second-generation PLINK: rising to the challenge of larger and richer datasets. Gigascience 4, 7 (2015).
Winkler, T. W. & Day, F. R. Quality control and conduct of genome-wide association meta-analyses. Nat. Protoc. 9, 1192–1212 (2014).
Willer, C. J., Li, Y. & Abecasis, G. R. METAL: fast and efficient meta-analysis of genomewide association scans. Bioinformatics 26, 2190–2191 (2010).
Turner, S.D. qqman: an R package for visualizing GWAS results using Q-Q and Manhattan plots. Preprint at bioRxiv https://doi.org/10.1101/005165 (2014).
Pruim, R. J. et al. LocusZoom: regional visualization of genome-wide association scan results. Bioinformatics 26, 2336–2337 (2010).
Gamazon, E. R. & Wheeler, H. E. A gene-based association method for mapping traits using reference transcriptome data. Nat. Genet. 47, 1091–1098 (2015).
Delaneau, O. & Marchini, J. Integrating sequence and array data to create an improved 1000 Genomes Project haplotype reference panel. Nat. Commun. 5, 3934 (2014).
Carithers, L. J. et al. A novel approach to high-quality postmortem tissue procurement: the GTEx project. Biopreserv. Biobank. 13, 311–319 (2015).
Sul, J. H., Han, B., Ye, C., Choi, T. & Eskin, E. Effectively identifying eQTLs from multiple tissues by combining mixed model and meta-analytic approaches. PLoS Genet. 9, e1003491 (2013).
Bulik-Sullivan, B. K. et al. LD score regression distinguishes confounding from polygenicity in genome-wide association studies. Nat. Genet. 47, 291–295 (2015).
Altshuler, D. M. et al. Integrating common and rare genetic variation in diverse human populations. Nature 467, 52–58 (2010).
Bulik-Sullivan, B. et al. An atlas of genetic correlations across human diseases and traits. Nat. Genet. 47, 1236–1241 (2015).
Hemani, G. et al. MR-Base: a platform for systematic causal inference across the phenome using billions of genetic associations. Preprint at bioRxiv https://doi.org/10.1101/078972 (2017).
Zhu, Z. et al. Causal associations between risk factors and common diseases inferred from GWAS summary data. Nat. Commun. 9, 224 (2018).
Davey Smith, G. & Hemani, G. Mendelian randomization: genetic anchors for causal inference in epidemiological studies. Hum. Mol. Genet. 23(R1), R89–R98 (2014).
Schizophrenia Working Group of the Psychiatric Genomics Consortium. Biological insights from 108 schizophrenia-associated genetic loci. Nature 511, 421–427 (2014).
Ehret, G. B. et al. Genetic variants in novel pathways influence blood pressure and cardiovascular disease risk. Nature 478, 103–109 (2011).
Bowden, J., Davey Smith, G., Haycock, P. C. & Burgess, S. Consistent estimation in Mendelian randomization with some invalid instruments using a weighted median estimator. Genet. Epidemiol. 40, 304–314 (2016).
Hartwig, F.P., Davey Smith, G. & Bowden, J. Robust inference in two-sample Mendelian randomisation via the zero modal pleiotropy assumption. Preprint at bioRxiv https://doi.org/10.1101/126102 (2017).
Bowden, J. et al. Assessing the suitability of summary data for two-sample Mendelian randomization analyses using MR-Egger regression: the role of the I
2 statistic. Int. J. Epidemiol. 45, 1961–1974 (2016).